Key facts
- Nanomunity’s last known valuation is $14.2M (Mar 2026).
- It has raised $3.2M; the latest was Early Stage VC ($3.2M) in Mar 2026.
- Notable investors include Incubateur Impulse, Remora Biotech.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Nanomunity
- ·The full record, as it builds
Funding rounds
No funding rounds for Nanomunity are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nanomunity
Developer of biotechnology intended to advance therapeutic applications in immuno-oncology. The company's platform uses nanobody-based approaches, multi-specific architectures, enhanced tissue penetration, and pre-clinical testing, enabling biotechnology firms and healthcare providers to access innovative therapeutic candidates and improve treatment efficacy.
- Sector
- Healthcare
- HQ
- Marseille, France
- Founded
- 2023
- Ownership
- Privately Held (backing)
Nanomunity doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nanomunity shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nanomunity in its N-PORT filings yet. We sweep new filings monthly.